TY  - JOUR
AU  - Tadić, Marin
AU  - Panjan, Matjaž
AU  - Lalatone, Yoann
AU  - Milošević, Irena
AU  - Vučetić Tadić, Biljana
AU  - Lazović, Jelena
PY  - 2022
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/10477
AB  - We investigate synthesis, phase evolution, hollow and porous structure and magnetic properties of quasi-amorphous intermediate phase (QUAIPH) and hematite (α-Fe2O3) nanostructure synthesized by annealing of akaganeite (β-FeOOH) nanorods. It is found that the annealing temperature determines the phase composition of the products, the crystal structure/size dictates the magnetic properties whereas the final nanorod morphology is determined by the starting material. Annealing of β-FeOOH at ∼300 °C resulted in the formation of hollow QUAIPH nanorods. The synthesized material shows low-cytotoxicity, superparamagnetism and good transverse relaxivity, which is rarely reported for QUAIPH. The QUAIPH nanorods started to transform to porous hematite nanostructures at ∼350 °C and phase transformation was completed at 600 °C. During the annealing, the crystal structure changed from monoclinic (akaganeite) to quasi-amorphous and rhombohedral (hematite). Unusually, the crystallite size first decreased (akaganeite → QUAIPH) and then increased (QUAIPH → hematite) during annealing whereas the nanorods retained particle shape. The magnetic properties of the samples changed from antiferromagnetic (akaganeite) to superparamagnetic with blocking temperature TB = 84 K (QUAIPH) and finally to weak-ferromagnetic with the Morin transition at TM = 244 K and high coercivity HC = 1652 Oe (hematite). The low-cytotoxicity and MRI relaxivity (r2 = 5.80 mM−1 s−1 (akaganeite), r2 = 4.31 mM−1 s−1 (QUAIPH) and r2 = 5.17 mM−1 s−1 (hematite)) reveal potential for biomedical applications.
T2  - Advanced Powder Technology
T1  - Magnetic properties, phase evolution, hollow structure and biomedical application of hematite (α-Fe2O3) and QUAIPH
VL  - 33
IS  - 12
SP  - 103847
DO  - 10.1016/j.apt.2022.103847
ER  - 

@article{
author = "Tadić, Marin and Panjan, Matjaž and Lalatone, Yoann and Milošević, Irena and Vučetić Tadić, Biljana and Lazović, Jelena",
year = "2022",
abstract = "We investigate synthesis, phase evolution, hollow and porous structure and magnetic properties of quasi-amorphous intermediate phase (QUAIPH) and hematite (α-Fe2O3) nanostructure synthesized by annealing of akaganeite (β-FeOOH) nanorods. It is found that the annealing temperature determines the phase composition of the products, the crystal structure/size dictates the magnetic properties whereas the final nanorod morphology is determined by the starting material. Annealing of β-FeOOH at ∼300 °C resulted in the formation of hollow QUAIPH nanorods. The synthesized material shows low-cytotoxicity, superparamagnetism and good transverse relaxivity, which is rarely reported for QUAIPH. The QUAIPH nanorods started to transform to porous hematite nanostructures at ∼350 °C and phase transformation was completed at 600 °C. During the annealing, the crystal structure changed from monoclinic (akaganeite) to quasi-amorphous and rhombohedral (hematite). Unusually, the crystallite size first decreased (akaganeite → QUAIPH) and then increased (QUAIPH → hematite) during annealing whereas the nanorods retained particle shape. The magnetic properties of the samples changed from antiferromagnetic (akaganeite) to superparamagnetic with blocking temperature TB = 84 K (QUAIPH) and finally to weak-ferromagnetic with the Morin transition at TM = 244 K and high coercivity HC = 1652 Oe (hematite). The low-cytotoxicity and MRI relaxivity (r2 = 5.80 mM−1 s−1 (akaganeite), r2 = 4.31 mM−1 s−1 (QUAIPH) and r2 = 5.17 mM−1 s−1 (hematite)) reveal potential for biomedical applications.",
journal = "Advanced Powder Technology",
title = "Magnetic properties, phase evolution, hollow structure and biomedical application of hematite (α-Fe2O3) and QUAIPH",
volume = "33",
number = "12",
pages = "103847",
doi = "10.1016/j.apt.2022.103847"
}

Tadić, M., Panjan, M., Lalatone, Y., Milošević, I., Vučetić Tadić, B.,& Lazović, J.. (2022). Magnetic properties, phase evolution, hollow structure and biomedical application of hematite (α-Fe2O3) and QUAIPH. in Advanced Powder Technology, 33(12), 103847.
https://doi.org/10.1016/j.apt.2022.103847

Tadić M, Panjan M, Lalatone Y, Milošević I, Vučetić Tadić B, Lazović J. Magnetic properties, phase evolution, hollow structure and biomedical application of hematite (α-Fe2O3) and QUAIPH. in Advanced Powder Technology. 2022;33(12):103847.
doi:10.1016/j.apt.2022.103847 .

Tadić, Marin, Panjan, Matjaž, Lalatone, Yoann, Milošević, Irena, Vučetić Tadić, Biljana, Lazović, Jelena, "Magnetic properties, phase evolution, hollow structure and biomedical application of hematite (α-Fe2O3) and QUAIPH" in Advanced Powder Technology, 33, no. 12 (2022):103847,
https://doi.org/10.1016/j.apt.2022.103847 . .

TY  - JOUR
AU  - Todorović, Lidija
AU  - Stamenković, Gorana
AU  - Vučetić-Tadić, Biljana
AU  - Umezawa, Kazuo
AU  - Božović, Ana M.
AU  - Yamashita, Shunichi
AU  - Stanojević, Boban
PY  - 2021
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/9413
AB  - The use of targeted inhibitors has shown promise as an effective approach in cancer therapy. However, targeted therapies based only on one drug, such as 17-allylamino-17-demethoxygeldanamycin (17-AAG), have limited success, partly because cancer cells engage alternate pathways for survival and proliferation. In the present study, we evaluated whether dehydroxymethylepoxyquinomicin (DHMEQ), a nuclear factor ?B (NF-?B) inhibitor, can enhance the antitumor activities of 17-AAG, a 90 kDa heat shock protein (Hsp90) inhibitor, in the anaplastic thyroid cancer cell line KTC2. We examined the effect of combined drug treatment vs single drug treatment on cell survival. Isobologram analysis was performed to distinguish the additive vs synergistic effects of the drug combination. Western blotting was performed to investigate apoptosis markers: caspase 3, poly(ADP-ribose) polymerase-one (PARP-1), B-cell lymphoma-extra large (Bcl-XL), X-linked inhibitor of apoptosis (XIAP) and cellular inhibitor of apoptosis 2 (cIAP-2). Compared to monotherapy, the combined treatment enhanced growth-inhibitory effects in a synergistic manner and strongly potentiated apoptosis. These results demonstrate the first in vitro evidence that a combination of Hsp90 and NF-?B inhibitors is a more effective modality for inhibiting cell proliferation and survival in anaplastic thyroid carcinoma cells than either agent alone, warranting further investigations.
T2  - Archives of Biological Sciences
T1  - Synergistic effect of 17-allylamino-17-demethoxygeldanamycin with dehydroxymethylepoxyquinomicin on the human anaplastic thyroid carcinoma cell line KTC2
VL  - 73
IS  - 1
SP  - 31
EP  - 38
DO  - 10.2298/ABS201010055T
ER  - 

@article{
author = "Todorović, Lidija and Stamenković, Gorana and Vučetić-Tadić, Biljana and Umezawa, Kazuo and Božović, Ana M. and Yamashita, Shunichi and Stanojević, Boban",
year = "2021",
abstract = "The use of targeted inhibitors has shown promise as an effective approach in cancer therapy. However, targeted therapies based only on one drug, such as 17-allylamino-17-demethoxygeldanamycin (17-AAG), have limited success, partly because cancer cells engage alternate pathways for survival and proliferation. In the present study, we evaluated whether dehydroxymethylepoxyquinomicin (DHMEQ), a nuclear factor ?B (NF-?B) inhibitor, can enhance the antitumor activities of 17-AAG, a 90 kDa heat shock protein (Hsp90) inhibitor, in the anaplastic thyroid cancer cell line KTC2. We examined the effect of combined drug treatment vs single drug treatment on cell survival. Isobologram analysis was performed to distinguish the additive vs synergistic effects of the drug combination. Western blotting was performed to investigate apoptosis markers: caspase 3, poly(ADP-ribose) polymerase-one (PARP-1), B-cell lymphoma-extra large (Bcl-XL), X-linked inhibitor of apoptosis (XIAP) and cellular inhibitor of apoptosis 2 (cIAP-2). Compared to monotherapy, the combined treatment enhanced growth-inhibitory effects in a synergistic manner and strongly potentiated apoptosis. These results demonstrate the first in vitro evidence that a combination of Hsp90 and NF-?B inhibitors is a more effective modality for inhibiting cell proliferation and survival in anaplastic thyroid carcinoma cells than either agent alone, warranting further investigations.",
journal = "Archives of Biological Sciences",
title = "Synergistic effect of 17-allylamino-17-demethoxygeldanamycin with dehydroxymethylepoxyquinomicin on the human anaplastic thyroid carcinoma cell line KTC2",
volume = "73",
number = "1",
pages = "31-38",
doi = "10.2298/ABS201010055T"
}

Todorović, L., Stamenković, G., Vučetić-Tadić, B., Umezawa, K., Božović, A. M., Yamashita, S.,& Stanojević, B.. (2021). Synergistic effect of 17-allylamino-17-demethoxygeldanamycin with dehydroxymethylepoxyquinomicin on the human anaplastic thyroid carcinoma cell line KTC2. in Archives of Biological Sciences, 73(1), 31-38.
https://doi.org/10.2298/ABS201010055T

Todorović L, Stamenković G, Vučetić-Tadić B, Umezawa K, Božović AM, Yamashita S, Stanojević B. Synergistic effect of 17-allylamino-17-demethoxygeldanamycin with dehydroxymethylepoxyquinomicin on the human anaplastic thyroid carcinoma cell line KTC2. in Archives of Biological Sciences. 2021;73(1):31-38.
doi:10.2298/ABS201010055T .

Todorović, Lidija, Stamenković, Gorana, Vučetić-Tadić, Biljana, Umezawa, Kazuo, Božović, Ana M., Yamashita, Shunichi, Stanojević, Boban, "Synergistic effect of 17-allylamino-17-demethoxygeldanamycin with dehydroxymethylepoxyquinomicin on the human anaplastic thyroid carcinoma cell line KTC2" in Archives of Biological Sciences, 73, no. 1 (2021):31-38,
https://doi.org/10.2298/ABS201010055T . .

TY  - JOUR
AU  - Tadić, Marin
AU  - Panjan, Matjaž
AU  - Vučetić Tadić, Biljana
AU  - Kralj, Slavko
AU  - Lazović, Jelena
PY  - 2021
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/10102
AB  - A porous hematite/alumina nanocomposite is produced by sol-gel combustion synthesis. The XRPD, Raman and FTIR methods show the presence of α-Fe2O3 phase while SEM, TEM, EDS and BET techniques further reveal the formation of porous ellipsoid-like nanostructure of hematite nanoparticles coated by amorphous alumina. Hematite nanoparticles have a size of ~40 nm whereas the porous hematite/alumina nanocomposite particles are ~100 nm in size with characteristic pores of ~7 nm. The M(H) at 300 K exhibits coercivity HC = 293 Oe and magnetization MS = 2.71 emu/g and at 5 K HC = 1150 Oe and MS = 9.25 emu/g. The M(T) under H = 100 Oe shows a bifurcation between ZFC/FC magnetization curves at all measurement temperatures Tirr>350 K (irreversibility temperature) and blocking temperature at TB ~ 305 K. Unexpectedly, the M(T) measurements under H = 10 kOe reveal the suppressed Morin transition at TM = 225 K. The analysis of the results and data from the literature reveal that the porous surface structure of hematite induces the atypical magnetic properties. A magnetic resonance imaging (MRI) properties show the transverse relaxivity rate (r2) of 0.44 mM−1s−1 at 7 T and 1.06 mM−1s−1 at 15.2 T. The investigated nanocomposite particles could be useful in biomedical applications due to their low cytotoxicity and porous nanostructure.
T2  - Ceramics International
T1  - Magnetic properties of mesoporous hematite/alumina nanocomposite and evaluation for biomedical applications
DO  - 10.1016/j.ceramint.2021.12.209
ER  - 

@article{
author = "Tadić, Marin and Panjan, Matjaž and Vučetić Tadić, Biljana and Kralj, Slavko and Lazović, Jelena",
year = "2021",
abstract = "A porous hematite/alumina nanocomposite is produced by sol-gel combustion synthesis. The XRPD, Raman and FTIR methods show the presence of α-Fe2O3 phase while SEM, TEM, EDS and BET techniques further reveal the formation of porous ellipsoid-like nanostructure of hematite nanoparticles coated by amorphous alumina. Hematite nanoparticles have a size of ~40 nm whereas the porous hematite/alumina nanocomposite particles are ~100 nm in size with characteristic pores of ~7 nm. The M(H) at 300 K exhibits coercivity HC = 293 Oe and magnetization MS = 2.71 emu/g and at 5 K HC = 1150 Oe and MS = 9.25 emu/g. The M(T) under H = 100 Oe shows a bifurcation between ZFC/FC magnetization curves at all measurement temperatures Tirr>350 K (irreversibility temperature) and blocking temperature at TB ~ 305 K. Unexpectedly, the M(T) measurements under H = 10 kOe reveal the suppressed Morin transition at TM = 225 K. The analysis of the results and data from the literature reveal that the porous surface structure of hematite induces the atypical magnetic properties. A magnetic resonance imaging (MRI) properties show the transverse relaxivity rate (r2) of 0.44 mM−1s−1 at 7 T and 1.06 mM−1s−1 at 15.2 T. The investigated nanocomposite particles could be useful in biomedical applications due to their low cytotoxicity and porous nanostructure.",
journal = "Ceramics International",
title = "Magnetic properties of mesoporous hematite/alumina nanocomposite and evaluation for biomedical applications",
doi = "10.1016/j.ceramint.2021.12.209"
}

Tadić, M., Panjan, M., Vučetić Tadić, B., Kralj, S.,& Lazović, J.. (2021). Magnetic properties of mesoporous hematite/alumina nanocomposite and evaluation for biomedical applications. in Ceramics International.
https://doi.org/10.1016/j.ceramint.2021.12.209

Tadić M, Panjan M, Vučetić Tadić B, Kralj S, Lazović J. Magnetic properties of mesoporous hematite/alumina nanocomposite and evaluation for biomedical applications. in Ceramics International. 2021;.
doi:10.1016/j.ceramint.2021.12.209 .

Tadić, Marin, Panjan, Matjaž, Vučetić Tadić, Biljana, Kralj, Slavko, Lazović, Jelena, "Magnetic properties of mesoporous hematite/alumina nanocomposite and evaluation for biomedical applications" in Ceramics International (2021),
https://doi.org/10.1016/j.ceramint.2021.12.209 . .

TY  - JOUR
AU  - Todorović, Lidija
AU  - Mandušić, Vesna
AU  - Vučetić-Tadić, Biljana
AU  - Živaljević, Vladan
AU  - Paunović, Ivan
AU  - Stanojević, Boban
PY  - 2020
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/9055
AB  - A growing number of studies suggest a tumor suppressive role and potential prognostic significance of miR- 30a-3p in different types of cancer. However, relatively few studies have focused on this microRNA in neoplastic thyroid lesions, including papillary thyroid cancer (PTC). The aim of our study was to shed more light on the potential involvement and clinical relevance of miR-30a-3p in this type of cancer. We examined the expression levels of this microRNA in 42 pairs of PTCs and matched non-tumor thyroid tissues using quantitative RT-PCR. We analyzed their association with clinical and histopathological parameters. The results revealed that miR-30a-3p was significantly downregulated in the majority of PTC tissues compared to corresponding non-tumor tissues. Moreover, decreased expression of miR-30a-3p was associated with advanced clinical stage, presence of multiple tumor foci and capsular invasion, suggesting a role in aggressive disease. Although the role of this microRNA and its prognostic utility remain to be elucidated, the presented data suggest that downregulated expression of miR-30a-3p indicates poorer prognosis in PTC patients, warranting further investigations.
T2  - Archives of Biological Sciences
T1  - Altered expression of microRNA-30a-3p in papillary thyroid cancer and its association with clinicopathological characteristics
VL  - 72
IS  - 1
SP  - 31
EP  - 36
DO  - 10.2298/ABS191004063T
ER  - 

@article{
author = "Todorović, Lidija and Mandušić, Vesna and Vučetić-Tadić, Biljana and Živaljević, Vladan and Paunović, Ivan and Stanojević, Boban",
year = "2020",
abstract = "A growing number of studies suggest a tumor suppressive role and potential prognostic significance of miR- 30a-3p in different types of cancer. However, relatively few studies have focused on this microRNA in neoplastic thyroid lesions, including papillary thyroid cancer (PTC). The aim of our study was to shed more light on the potential involvement and clinical relevance of miR-30a-3p in this type of cancer. We examined the expression levels of this microRNA in 42 pairs of PTCs and matched non-tumor thyroid tissues using quantitative RT-PCR. We analyzed their association with clinical and histopathological parameters. The results revealed that miR-30a-3p was significantly downregulated in the majority of PTC tissues compared to corresponding non-tumor tissues. Moreover, decreased expression of miR-30a-3p was associated with advanced clinical stage, presence of multiple tumor foci and capsular invasion, suggesting a role in aggressive disease. Although the role of this microRNA and its prognostic utility remain to be elucidated, the presented data suggest that downregulated expression of miR-30a-3p indicates poorer prognosis in PTC patients, warranting further investigations.",
journal = "Archives of Biological Sciences",
title = "Altered expression of microRNA-30a-3p in papillary thyroid cancer and its association with clinicopathological characteristics",
volume = "72",
number = "1",
pages = "31-36",
doi = "10.2298/ABS191004063T"
}

Todorović, L., Mandušić, V., Vučetić-Tadić, B., Živaljević, V., Paunović, I.,& Stanojević, B.. (2020). Altered expression of microRNA-30a-3p in papillary thyroid cancer and its association with clinicopathological characteristics. in Archives of Biological Sciences, 72(1), 31-36.
https://doi.org/10.2298/ABS191004063T

Todorović L, Mandušić V, Vučetić-Tadić B, Živaljević V, Paunović I, Stanojević B. Altered expression of microRNA-30a-3p in papillary thyroid cancer and its association with clinicopathological characteristics. in Archives of Biological Sciences. 2020;72(1):31-36.
doi:10.2298/ABS191004063T .

Todorović, Lidija, Mandušić, Vesna, Vučetić-Tadić, Biljana, Živaljević, Vladan, Paunović, Ivan, Stanojević, Boban, "Altered expression of microRNA-30a-3p in papillary thyroid cancer and its association with clinicopathological characteristics" in Archives of Biological Sciences, 72, no. 1 (2020):31-36,
https://doi.org/10.2298/ABS191004063T . .